Method for tolerizing a mammalian patient to administration...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/70 (2006.01) A61K 39/12 (2006.01)

Patent

CA 2264924

A method for tolerizing a mammalian subject to administration of a live virus carrying a gene for delivery to a cell of the subject is disclosed. The method entails administering to the subject a suitable amount of an inactivated virus prior to administration of the live virus. The prior administration of the inactivated virus suppresses anti-virus cytotoxic T cells, permitting longer transgene persistence once the live virus is administered, and permitting effective readministration of live virus.

L'invention concerne un procédé pour rendre un sujet mammifère tolérant à l'administration d'un virus actif portant un gène destiné à une cellule dudit sujet. Ce procédé implique d'administrer au sujet une quantité appropriée d'un virus inactivé avant de lui administrer le virus actif. Cette administration préalable du virus inactivé supprime les cellules T cytotoxiques antivirales, ce qui permet une persistance transgène plus longue une fois que le virus est administré et rend plus efficace une réadministration du virus actif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for tolerizing a mammalian patient to administration... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for tolerizing a mammalian patient to administration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for tolerizing a mammalian patient to administration... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2069823

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.